Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GVK BIO, a discovery research and development firm, has signed a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization (CRO) operating out of Chennai, India.
Subscribe to our email newsletter
Complying with OECD GLP, ISO, US FDA GLP regulatory guidelines, Vanta offers toxicology evaluation services for the pharmaceutical, biotech, food supplements and feed additives industries.
The acquisition allows GVK BIO to offer GLP toxicology services for pharmaceuticals, agrochemicals, nutraceuticals and cosmetics.
GVK BIO CEO Manni Kantipudi said: "The acquisition is in line with our business strategy of being an integrated drug discovery services provider for our customers.
"We are constantly investing in upgrading our capabilities to provide world-class R&D services. Vanta Bioscience further advances our position as we expand our service offering in GLP toxicology."
The GLP and AAALAC accredited facility is equipped with high-end equipment, and has infrastructure like ‘Individually ventilated Cages’ and ‘Intelligent Building Management’ systems.
It houses GLP trained scientific personnel with experience and expertise in study design and execution of regulatory directed studies leading to IND filings.